German Christopher Paul sold RYTM
July 9, 2025 · Form 4 insider transaction
German Christopher Paul sold 1,850 shares of Rhythm Pharmaceuticals, Inc. at $85.00 per share, a transaction worth $157.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,850
Price
$85.00
Total value
$157.3K
InsiderGerman Christopher Paul
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 9, 2025
Filing dateJuly 11, 2025
Shares owned after922
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2025.